Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Toshner

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Visualized Experiments : Jove|January 19, 2016
Generation and Culture of Blood Outgrowth Endothelial Cells from Human Peripheral BloodMark L Ormiston, Mark R Toshner, Fedir N Kiskin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2010
Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertensionMark R Toshner, Deepa Gopalan, Jay Suntharalingam, et al.
Trials|October 15, 2024
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2Nina Deliu, Rajenki Das, Angelique May, et al.
Chest|February 12, 2008
Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertensionJay Suntharalingam, Carmen M Treacy, Natalie J Doughty, et al.
Thorax|February 8, 2011
Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertensionElaine Soon, Carmen M Treacy, Mark R Toshner, et al.
The European Respiratory Journal|April 18, 2020
Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?Eleni Sofianopoulou, Colin Church, Gerry Coghlan, et al.
Thorax|February 9, 2007
Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertensionJay Suntharalingam, Rajiv D Machado, Linda D Sharples, et al.
Pulmonary Circulation|August 31, 2018
Hematopoietic stem cell transplantation alters susceptibility to pulmonary hypertension in Bmpr2-deficient miceAlexi Crosby, Mark R Toshner, Mark R Southwood, et al.
The European Respiratory Journal|November 10, 2018
Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertensionEmilia Maria Swietlik, Alessandro Ruggiero, Andrew J Fletcher, et al.
Angiogenesis|November 12, 2025
BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivityBenjamin J Dunmore, Stephen Moore, Rowena J Jones, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Visualized Experiments : Jove|January 19, 2016
Generation and Culture of Blood Outgrowth Endothelial Cells from Human Peripheral BloodMark L Ormiston, Mark R Toshner, Fedir N Kiskin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2010
Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertensionMark R Toshner, Deepa Gopalan, Jay Suntharalingam, et al.
Trials|October 15, 2024
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2Nina Deliu, Rajenki Das, Angelique May, et al.
Chest|February 12, 2008
Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertensionJay Suntharalingam, Carmen M Treacy, Natalie J Doughty, et al.
Thorax|February 8, 2011
Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertensionElaine Soon, Carmen M Treacy, Mark R Toshner, et al.
The European Respiratory Journal|April 18, 2020
Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?Eleni Sofianopoulou, Colin Church, Gerry Coghlan, et al.
Thorax|February 9, 2007
Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertensionJay Suntharalingam, Rajiv D Machado, Linda D Sharples, et al.
Pulmonary Circulation|August 31, 2018
Hematopoietic stem cell transplantation alters susceptibility to pulmonary hypertension in Bmpr2-deficient miceAlexi Crosby, Mark R Toshner, Mark R Southwood, et al.
The European Respiratory Journal|November 10, 2018
Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertensionEmilia Maria Swietlik, Alessandro Ruggiero, Andrew J Fletcher, et al.
Angiogenesis|November 12, 2025
BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivityBenjamin J Dunmore, Stephen Moore, Rowena J Jones, et al.
Pageof 4